Boeckxstaens GE, Beaumont H, Hatlebakk JG et al. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Gut. 2011;60:1182e1188.

[pdf-embedder url=”https://iwgco.net/wp-content/uploads/securepdfs/2021/12/Boeckxstaens-Gut-2011.pdf” title=”Boeckxstaens Gut 2011″]

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .

IWGCO Email Support

Please contact us if you are having trouble using an IWGCO educati0nal program.  We will do our best to respond promptly to your email, but please keep in mind that IWGCO is a voluntary organization.